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Abstract
Background: Breast cancer is the most common cancer in females, both in developed and
developing countries. Pakistan has the highest breast cancer incidence rate in Asia. Guidelines
recommend screening for detecting breast cancer with mammography and ultrasonography
(US). Shear-wave elastography (SWE) is a newer technique that can aid additional
characterization of breast lesions. 
Objective: The aim of this study was to determine the diagnostic accuracy of breast ultrasound
elastography in differentiating benign from malignant breast lesions using histology diagnosis
as the gold standard.
Materials and methods: The study was conducted at the Abbasi Shaheed Hospital and Jinnah
Post Graduate Medical Centre, Karachi. All consecutive patients undergoing breast biopsy and
elastography of breast lesions were enlisted; 2 x 2 tables were used to measure the sensitivity,
specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic
accuracy of breast ultrasound elastography for differentiation of benign from malignant breast
masses.
Results: A total of 155 female patients were included with a mean age of 45.41 ± 14.24 years
(range 20-70 years). On histological evaluation, 115 (74.2%) lesions were malignant and 40
(25.8%) were benign. The overall average mean elastography value was 108.45 kPa ± 52.75. The
mean elastography (EMean) value for benign breast lesions was 48.96 kPa ± 42.32 and 132.78
kPa ± 42.32 for malignant lesions. The difference in mean elastography values of benign and
malignant breast lesions was statistically significant (48.96 kPa ± 42.32 vs 32.78 kPa ± 42.32, P
<0.001). The area under the curve (AUC) was 0.952, optimal cutoff EMean value of 72 kPa and
higher likelihood ratio was 9.41. A cutoff mean elastography (EMean) value of ≤ 72 kilopascal
(kPa) for benign lesions had sensitivity 92.17%, specificity 90.4%, PPV 96.36%, NPV 80.0%
and diagnostic accuracy 91.61%. 
Conclusion: Ultrasound elastography was found to have high sensitivity and specificity and
diagnostic accuracy for differentiating benign from malignant breast lesions. Use of shear-wave
elastography may increase malignancy detection rate by reducing the need for biopsy in benign
breast lesions.
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Introduction
Breast cancer is the most common cancer diagnosed in women globally and the second most
common malignancy overall, after lung cancer [1-2]. The incidence of breast cancer has been
on the rise over the last few decades. The incidence of breast cancer is the highest in Pakistan
(50.1/100,000) [3]. Data collected from 1995-1997 shows that breast cancer accounts for almost
one-third of all female cancers in Karachi [3]. With more than half the population at risk, the
incidence of breast cancer has alarmingly increased over the last few decades [4]. Breast cancer
is uncommon before age 25 but the risk steadily increases with age, doubling every 10 years
until menopause and slows dramatically afterwards [5].
Mammography is a valuable modality for screening in breast cancer however has low sensitivity
in dense breast tissue [6-7]. The sensitivity of mammography in breast cancer is reduced from
an overall 85% to 47.8%-64.4% in dense breast tissue [8]. Breast ultrasound is another
diagnostic modality available for the evaluation of breast lesions and is common in clinical
practice due to its higher sensitivity. There is some advocacy for breast ultrasound to be the
primary imaging modality in the evaluation of breast lesions [9]. The Breast Imaging Reporting
and Data System (BIRADS) along with ultrasonographic (US) descriptors are used to
characterize and categorize breast lesions [10]. Breast ultrasound has its limitations; limited
ability to distinguish isoechoic lesions from surrounding fat, inability to image areas deep
within the breast, and poor detection of microcalcifications [11]. 
Ultrasound elastography is a newer modality which assesses the tissue differences regarding
stiffness or elasticity of lesions that were, historically assessed by palpation [12]. Elastography
was first introduced in 1990 and entered clinical practice in 1997 [13-14]. 
Elastography is a non-invasive imaging technique in which local tissue strains are measured
directly or indirectly by application of external stress. The tissue displacement is measured and
a calculation of tissue stiffness is made based on tissue displacement [12]. Shear-wave
elastography (SWE) reduces operator dependency which was encountered previously in free
hand elastography [15]. A quantitative assessment of viscoelastic properties of tissue is
obtained by inducing mechanical vibrations through a focused beam, which is expressed as
Young’s modulus or displayed as a color overlay of the lesion [16]. SWE is reported to have
excellent diagnostic performance in distinguishing benign breast masses from malignant
lesions [17].
SWE is gaining popularity in clinical practice in Pakistan; however there is scarcity of
published literature from local institutions [18]. The purpose of this study was to determine the
diagnostic accuracy of breast ultrasound elastography in distinguishing benign breast lesions
from malignant breast lesions keeping histopathological diagnosis as the gold standard.
Materials And Methods
The dual center study prospective study was conducted at the Abbasi Shaheed Hospital and
Jinnah Post Graduate Medical Centre, from June 2017 to February 2018. Approval for the study
was obtained from institutional Ethical Review Committee of Jinnah Post Graduate Medical
Centre. Informed consent was obtained from all patients prior to their enrollment in the study.
All females between the ages of 20 and 60 referred for evaluation of palpable breast lumps were
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included. Patients who had cystic breast lesions, post surgical or chemoradiation status, the
clinical picture of infection or breast abscess were excluded from the study. Patients were also
excluded if they had breast implants, had undergone a prior biopsy of breast lesions under
examination or the lesion was subcentimeter. The final study population consisted of 155
patients.
US elastography was performed and interpreted by two experienced consultant radiologists
with more than five years of post-fellowship experience. On a predefined proforma, the clinical
history and physical examination findings were recorded. 
A dedicated breast ultrasound was performed with Aixplorer (SuperSonic Imagine, Aix-en-
Provence, France). The lesions were classified on gray scale ultrasound and color doppler
imaging as BIRADS US category 2, category 3, category 4 and category 5. SWE of all lesions was
performed using multi-Q box elastography and mean elastography (EMean) value was recorded
on a predefined proforma along with clinical history, grayscale ultrasound findings, and
subsequently histopathological diagnosis. All lesions were subjected to gray-scale ultrasound,
color doppler imaging and multi-Q box elastography values were evaluated. The mean
elastography (EMean) value was recorded for each lesion. The lesions were classified to
individual categories of BIRADS category 2, category 3, category 4 and category 5. BIRADS
category 1 lesions were excluded from the study. All lesions from BI-RADS US II-V were
subjected to histopathology. 
The range of elastography values was plotted and mean elastography (E Mean) values were
calculated for all lesions. A cutoff mean elastography (EMean) value of ≤ 72 kPa was set for
benign lesions and ≥ 102 kPa for malignant lesions. Lesions with mean elastography (EMean)
values between 72-102 (kPa) were suspected to be malignant. 
The statistical analysis was performed using free statistical software package R (version 3.5.2)
[19]. Using 2 x 2 tables, the sensitivity, specificity, positive predictive value, negative predictive
value, and diagnostic accuracy were determined. Receiver operator characteristics (ROC) curve
were also determined. The area under the ROC curve (AUC) analysis was performed to
determine the optimal cutoff value of mean elastography value. A two-tailed p-value <0.05 was
considered statistically significant.
Results
The final study sample comprised of 155 women with a mean age of 45.41 ± 14.24 years (range
20-70 years).
The overall mean elastography value (EMean) was 108.45 kPa ± 52.75. The mean elastography
value was 48.96 kPa ± 42.32 for benign lesions and 132.78 kPa ± 42.32 for malignant lesions,
with statistically significant difference in the mean elastography values between the benign
and malignant lesions (P<0.001). 
On histopathological evaluation, 115 (74.2%) were found to be malignant and 40 (25.8%) were
benign. On the basis of elastography values, 110 lesions were labelled as malignant or
suspicious of malignancy and 45 were labelled as benign (Table 1). Based on the BIRADS US
assessment, 34 (21.9%) lesions were labelled as benign and 121 as malignant or suspicious of
malignancy.
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Table 1: Comparison of histopathological diagnosis with Elastography
Elastography
Histopathology Diagnosis (BIRADS US Assessment)
P-value Kappa Value
Positive (III-V) Negative (II) Total
Positive 106(68.4%) 4(2.6%) 110(71%)
<0.001* 0.79Negative 9(5.8%) 36(23.2%) 45(29%)
Total 115(74.2%) 40(25.8%) 155(100%)
TABLE 1: Comparison of histopathological diagnosis with elastography
BIRADS: Breast Imaging Reporting and Data System.
SWE had sensitivity 92.17%, specificity 90.4%, PPV 96.36% and NPV 80.0% and an overall
diagnostic accuracy 91.61% (95% confidence Interval, 86.08% to 95.46%; P= <0.001) in
diagnosing benign breast lesions (Table 2). The area under the curve was 0.952 (95% Confidence
Interval, 0.916 to 0.9879; P= <0.01), the AUROC cutoff < 72 and higher likelihood ratio was 9.41
(Figures 1-3).
Table 2: Diagnostic accuracy of breast ultrasound elastography score









≤ 72 92.17 (85.66% to 96.36%) 90.43 (83.53% to 95.13%) 9.41 0.952 (0.916 to 0.9879) <0.001
TABLE 2: Diagnostic accuracy of breast ultrasound elastography score
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FIGURE 1: Receiver operator characteristics (ROC) curve
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FIGURE 2: Scatter plot diagram between histopathology
diagnosis & elastography score value
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FIGURE 3: Whisker’s Box plot of range of elastography values
(benign/malignant)
Discussion
While elastography imaging has been under evaluation for breast imaging, there has been a
renewed focus in recent years. The main disadvantages of static elastography were the inability
to provide a quantitative assessment and significant interobserver variability [20]. The main
advantage of SWE over conventional elastography is its higher reproducibility and objectivity,
as it allows to "move" the tissue by itself without the aid of external compression by transducer
[21]. Many shear wave electrographic parameters can be used for the assessment of breast
lesions related to elasticity values, i.e., minimum (EMin), mean (EMean), and maximum (EMax).
EMin, EMean, and EMax represent the stiffness of the lesion whereas E Ratio represents the
relative stiffness of the lesion to fat tissue which has a coherent elasticity value (3 kPa) [22].
Published literature suggests a higher sensitivity of Emax and higher specificity of Eratio
parameters [17,23-24].
The reproducibility of SWE parameters as a useful biomarker for differentiation of benign and
malignant breast lesions has been variable in the published literature with reported sensitivity
and specificity of SWE ranging from 70.1%-98.6%, and 45.7%-98.5% respectively [20,23]. With
an overall sensitivity of 92%, our initial experience with SWE has shown that it is useful in the
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characterization of benign breast lesions. Our study results are similar to other published
studies. Berg et al. in a large multinational study demonstrated that elastography could reduce
unnecessary biopsies of low‐suspicion category 4a masses [25].
Our results are similar to Athanasiou et al. who reported a mean elasticity value of 45.3 kPa for
benign lesions and 146.6 kPa for malignant lesions [26]. The mean elastography value in our
study was 48.96 kPa for benign lesions and 132.78 kPa for malignant lesions. The difference in
the mean elastography values of benign and malignant lesions was statistically significant
(P<0.001).
BIRADS US Category 3 lesions are more frequently malignant than non-palpable lesions in this
category, this was also noted in our study [27]. The most common age of patients with
malignant lesions was between 40 and 60 years. This is consistent with prior studies as the
prevalence of breast cancer is highest in this age group [5]. 
Fibroadenoma is a common benign tumor, resulting from an excess proliferation of connective
tissue and is often subjected to percutaneous biopsy [28]. A study by Masroor et al. showed that
80% of all biopsied breast lesions were benign in the Pakistani population [29]. This is similar to
other studies, that have reported a cancer detection rate of only 10%-30% on breast biopsy
[17]. Biopsy of a benign lesion causes physical and emotional discomfort along with increased
cost. In a country where obtaining breast biopsy is limited to a few centers, the overwhelming
rate of benign results on breast biopsy can be reduced by the use of elastography. An example
of fibroadenoma is shown below, with low EMean value of 5.7 kPa (Figure 4). 
FIGURE 4: Breast lesion with low mean elastography value,
which was diagnosed as fibroadenoma
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There are limitations of our study. In our study, 74% of breast lesions biopsied were malignant
on histological evaluation. This high malignancy detection rate is not in keeping with local and
international studies. This may be explained by a small sample size and possible subject
selection bias. A larger study is therefore being planned for future research. 
Early diagnosis and treatment of breast cancer are crucial for better prognosis. Biopsy of
breast lesion provides definitive diagnosis however dedicated breast biopsy facilities in
Pakistan cannot keep up with the increasing demand [30]. Therefore, recent developments in
elasticity imaging may be applied in the clinical setting for reliable characterization of benign
breast lesions. Breast elastography may reduce biopsy of benign lesions and increase the time
required for follow-up, translating into increased malignancy detection rate. Although further
research is necessary, our initial results are promising.
Conclusions
BIRADS assessment is improved by SWE in differentiating benign from malignant breast
lesions. A cutoff mean elastography (EMean) value of ≤ 72 kPa is highly sensitive and specific for
characterizing benign lesions. Use of shear-wave elastography may increase malignancy
detection rate by reducing the need for biopsy in benign breast lesions.
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